ORALE ZUBEREITUNGEN MIT OMEPRAZOL ODER PANTOPRAZOL
申请人:Symrise AG
公开号:EP3380085A1
公开(公告)日:2018-10-03
ORAL PREPARATIONS WITH OMEPRAZOLE OR PANTOPRAZOLE
申请人:SYMRISE AG
公开号:US20190240187A1
公开(公告)日:2019-08-08
Proposed is a preparation comprising
(a) omeprazole and/or pantoprazole; and
(b) eriodyctiol and/or homoeriodyctiol.
[DE] ORALE ZUBEREITUNGEN MIT OMEPRAZOL ODER PANTOPRAZOL<br/>[EN] ORAL PREPARATIONS WITH OMEPRAZOLE OR PANTOPRAZOLE<br/>[FR] PRÉPARATIONS ORALES CONTENANT DE L'OMÉPRAZOLE OU DU PANTOPRAZOLE
申请人:SYMRISE AG
公开号:WO2017088936A1
公开(公告)日:2017-06-01
Vorgeschlagen wird eine Zubereitung, enthaltend (a) Omeprazol und/oder Pantoprazol und (b) Eriodyctiol und/oder Homoeriodyctiol.
[EN] EXTRACT CONTAINING OLEANDRIN AND METHOD OF PRODUCTION THEREOF<br/>[FR] EXTRAIT CONTENANT DE L'OLÉANDRINE ET SON PROCÉDÉ DE PRODUCTION
申请人:PHOENIX BIOTECHNOLOGY INC
公开号:WO2021242590A1
公开(公告)日:2021-12-02
A subcritical liquid extraction process for the production of oleandrin or oleandrin- containing extract is provided. The process provides improvements over other methods of preparing oleandrin-containing extract. The extract, pharmaceutical compositions, dosage forms and nutraceutical compositions comprising oleandrin or said extract are provided. Methods of treating diseases, disorders or conditions that are therapeutically responsive to oleandrin are also provided.
Impact of mono- and disubstitution on the colorimetric dynamic covalent switching chalcone/flavanone scaffold
作者:Brian M. Muller、Jesse Mai、Reid A. Yocum、Marc J. Adler
DOI:10.1039/c4ob00398e
日期:——
The impact of substitution on a novel colorimetric dynamic covalent switching scaffold was investigated using UV/Vis and NMR spectroscopy.